266 related articles for article (PubMed ID: 24989170)
21. Interchangeability of two Enterovirus 71 inactivated vaccines in Chinese children: A phase IV, open-label, and randomized controlled trial.
Xu Q; Cao Q; Yang W; Liu X; Liu H; Tian X; Li J; Fang X; Jia N; Zeng G; Xu A
Vaccine; 2020 Mar; 38(12):2671-2677. PubMed ID: 32067817
[TBL] [Abstract][Full Text] [Related]
22. Identification and characterization of a cross-neutralization epitope of Enterovirus 71.
Liu CC; Chou AH; Lien SP; Lin HY; Liu SJ; Chang JY; Guo MS; Chow YH; Yang WS; Chang KH; Sia C; Chong P
Vaccine; 2011 Jun; 29(26):4362-72. PubMed ID: 21501643
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of monovalent and bivalent vaccines against lethal Enterovirus 71 and Coxsackievirus A16 infection in newborn mice.
Sun S; Jiang L; Liang Z; Mao Q; Su W; Zhang H; Li X; Jin J; Xu L; Zhao D; Fan P; An D; Yang P; Lu J; Lv X; Sun B; Xu F; Kong W; Jiang C
Hum Vaccin Immunother; 2014; 10(10):2885-95. PubMed ID: 25483672
[TBL] [Abstract][Full Text] [Related]
24. Crystal Structures of Yeast-Produced Enterovirus 71 and Enterovirus 71/Coxsackievirus A16 Chimeric Virus-Like Particles Provide the Structural Basis for Novel Vaccine Design against Hand-Foot-and-Mouth Disease.
Lyu K; He YL; Li HY; Chen R
J Virol; 2015 Jun; 89(12):6196-208. PubMed ID: 25833050
[TBL] [Abstract][Full Text] [Related]
25. Correlates of protection for inactivated enterovirus 71 vaccine: the analysis of immunological surrogate endpoints.
Zhu W; Jin P; Li JX; Zhu FC; Liu P
Expert Rev Vaccines; 2017 Sep; 16(9):945-949. PubMed ID: 28548626
[TBL] [Abstract][Full Text] [Related]
26. Expression of VP1 protein in the milk of transgenic mice: a potential oral vaccine protects against enterovirus 71 infection.
Chen HL; Huang JY; Chu TW; Tsai TC; Hung CM; Lin CC; Liu FC; Wang LC; Chen YJ; Lin MF; Chen CM
Vaccine; 2008 Jun; 26(23):2882-9. PubMed ID: 18450335
[TBL] [Abstract][Full Text] [Related]
27. The compatibility of inactivated-Enterovirus 71 vaccination with Coxsackievirus A16 and Poliovirus immunizations in humans and animals.
Mao Q; Wang Y; Shao J; Ying Z; Gao F; Yao X; Li C; Ye Q; Xu M; Li R; Zhu F; Liang Z
Hum Vaccin Immunother; 2015; 11(11):2723-33. PubMed ID: 25715318
[TBL] [Abstract][Full Text] [Related]
28. Immunity and clinical efficacy of an inactivated enterovirus 71 vaccine in healthy Chinese children: a report of further observations.
Liu L; Mo Z; Liang Z; Zhang Y; Li R; Ong KC; Wong KT; Yang E; Che Y; Wang J; Dong C; Feng M; Pu J; Wang L; Liao Y; Jiang L; Tan SH; David P; Huang T; Zhou Z; Wang X; Xia J; Guo L; Wang L; Xie Z; Cui W; Mao Q; Liang Y; Zhao H; Na R; Cui P; Shi H; Wang J; Li Q
BMC Med; 2015 Sep; 13():226. PubMed ID: 26381232
[TBL] [Abstract][Full Text] [Related]
29. Protective effect of enterovirus‑71 (EV71) virus‑like particle vaccine against lethal EV71 infection in a neonatal mouse model.
Cao L; Mao F; Pang Z; Yi Y; Qiu F; Tian R; Meng Q; Jia Z; Bi S
Mol Med Rep; 2015 Aug; 12(2):2473-80. PubMed ID: 25936344
[TBL] [Abstract][Full Text] [Related]
30. Immunization with virus-like particles of enterovirus 71 elicits potent immune responses and protects mice against lethal challenge.
Chung YC; Ho MS; Wu JC; Chen WJ; Huang JH; Chou ST; Hu YC
Vaccine; 2008 Mar; 26(15):1855-62. PubMed ID: 18329759
[TBL] [Abstract][Full Text] [Related]
31. Immunization with recombinant enterovirus 71 viral capsid protein 1 fragment stimulated antibody responses in hamsters.
Ch'ng WC; Stanbridge EJ; Wong KT; Ong KC; Yusoff K; Shafee N
Virol J; 2012 Aug; 9():155. PubMed ID: 22877087
[TBL] [Abstract][Full Text] [Related]
32. Transplantation of Enterovirus 71 Virion Protein Particle Vaccine Protects Against Enterovirus 71 Infection in a Neonatal Mouse Model.
Lei L; Li Q; Xu S; Tian M; Zheng X; Bi Y; Huang B
Ann Transplant; 2021 Jan; 26():e924461. PubMed ID: 33397838
[TBL] [Abstract][Full Text] [Related]
33. Enterovirus type 71 neutralizing antibodies in the serum of macaque monkeys immunized with EV71 virus-like particles.
Lin YL; Yu CI; Hu YC; Tsai TJ; Kuo YC; Chi WK; Lin AN; Chiang BL
Vaccine; 2012 Feb; 30(7):1305-12. PubMed ID: 22214888
[TBL] [Abstract][Full Text] [Related]
34. Pilot scale production of highly efficacious and stable enterovirus 71 vaccine candidates.
Chou AH; Liu CC; Chang CP; Guo MS; Hsieh SY; Yang WH; Chao HJ; Wu CL; Huang JL; Lee MS; Hu AY; Lin SC; Huang YY; Hu MH; Chow YH; Chiang JR; Chang JY; Chong P
PLoS One; 2012; 7(4):e34834. PubMed ID: 22529942
[TBL] [Abstract][Full Text] [Related]
35. Comparative analysis of the immunogenicity and protective effects of inactivated EV71 vaccines in mice.
Mao Q; Dong C; Li X; Gao Q; Guo Z; Yao X; Wang Y; Gao F; Li F; Xu M; Yin W; Li Q; Shen X; Liang Z; Wang J
PLoS One; 2012; 7(9):e46043. PubMed ID: 23029378
[TBL] [Abstract][Full Text] [Related]
36. Immune responses to baculovirus-displayed enterovirus 71 VP1 antigen.
Kiener TK; Premanand B; Kwang J
Expert Rev Vaccines; 2013 Apr; 12(4):357-64. PubMed ID: 23560917
[TBL] [Abstract][Full Text] [Related]
37. A virus-like particle based bivalent vaccine confers dual protection against enterovirus 71 and coxsackievirus A16 infections in mice.
Ku Z; Liu Q; Ye X; Cai Y; Wang X; Shi J; Li D; Jin X; An W; Huang Z
Vaccine; 2014 Jul; 32(34):4296-303. PubMed ID: 24950363
[TBL] [Abstract][Full Text] [Related]
38. Recombinant tandem multi-linear neutralizing epitopes of human enterovirus 71 elicited protective immunity in mice.
Li YX; Zhao H; Cao RY; Deng YQ; Han JF; Zhu SY; Ma J; Liu L; Qin ED; Qin CF
Virol J; 2014 May; 11():79. PubMed ID: 24885030
[TBL] [Abstract][Full Text] [Related]
39. Efficacy, safety, and immunology of an inactivated alum-adjuvant enterovirus 71 vaccine in children in China: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
Zhu FC; Meng FY; Li JX; Li XL; Mao QY; Tao H; Zhang YT; Yao X; Chu K; Chen QH; Hu YM; Wu X; Liu P; Zhu LY; Gao F; Jin H; Chen YJ; Dong YY; Liang YC; Shi NM; Ge HM; Liu L; Chen SG; Ai X; Zhang ZY; Ji YG; Luo FJ; Chen XQ; Zhang Y; Zhu LW; Liang ZL; Shen XL
Lancet; 2013 Jun; 381(9882):2024-32. PubMed ID: 23726161
[TBL] [Abstract][Full Text] [Related]
40. Pros and cons of VP1-specific maternal IgG for the protection of Enterovirus 71 infection.
Kim YI; Song JH; Kwon BE; Kim HN; Seo MD; Park K; Lee S; Yeo SG; Kweon MN; Ko HJ; Chang SY
Vaccine; 2015 Nov; 33(48):6604-10. PubMed ID: 26529069
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
